PubMed Health⌕ Search

Biomedical subjects

B B Gorzalka

Publications and source records attributed to B B Gorzalka.

At least 73 records · Page 4Linked to original sources

Testosterone removal in rats results in a decrease in social aggression and a loss of social dominance.

Alpha male rats from mixed sex colony groups were tested for aggressiveness toward nonaggressive male intruders. Afterward, they were castrated and implanted with testosterone filled Silastic tubes, castrated and implanted with empty tubes, or sham castrated and implanted with empty tubes. There were significant declines in the aggressiveness (lateral attacks, bites, and piloerection but not on-top) of castrated rats without testosterone replacement but not in castrated rats with testosterone replacement. At a second operation, castrated animals had their testosterone capsules removed or had their empty capsules replaced with testosterone filled capsules. When tested for aggression toward nonaggressive intruders, those alpha males which had testosterone removed declined in aggressiveness while those which had it implanted returned to a level of aggressiveness close to that emitted by sham castrated control animals. Subordinate males became dominant when alpha males were castrated and not given testosterone replacement. In a final series of observations, sham castrated males were found to be more aggressive than castrated males when pitted against one another. It is argued that testosterone plays a primary role in intermale social aggression and that the decline in aggressiveness following castration is typically accompanied by a loss of social dominance.

Aggression↗

Dual effect of morphiceptin on lordosis behavior: possible mediation by different opioid receptor subtypes.

Intracerebroventricular (ICV) infusions of the selective mu receptor agonist morphiceptin produce a dual effect on lordosis behavior in ovariectomized, steroid-primed rats. Low doses of morphiceptin (20 ng) inhibit lordosis whereas higher doses (2000 ng) facilitate this behavior. The present experiment tested whether naloxone, an antagonist of both high- and low-affinity mu receptors, or the long-acting high-affinity mu receptor antagonist naloxazone could block the dual effect of morphiceptin on lordosis. Ovariectomized rats primed with estrogen and progesterone received naloxone, naloxazone, or a control solution prior to ICV infusions of either 0, 20, or 2000 ng of morphiceptin. Naloxone reversed both the inhibition and facilitation of lordosis produced by morphiceptin, but had no effect on lordosis when administered before control infusions. In contrast, naloxazone reversed the inhibition but not the facilitation of lordosis. These results indicate that the inhibitory effect of morphiceptin on lordosis reflects the activation of high-affinity mu receptors whereas the facilitatory effect reflects either the activation of low-affinity mu receptors or other opioid receptor subtypes. The failure of naloxone or naloxazone to affect lordosis in rats receiving control infusions of saline further suggests that endogenous opioid systems do not exert a tonic inhibitory or facilitatory action on lordosis behavior.

Analgesics↗

Harmine reverses the inhibition of lordosis by the 5-HT2 antagonists pirenperone and ketanserin in the female rat.

The beta-carboline harmine was found to facilitate lordosis behavior in ovariectomized rats primed with estradiol benzoate. Moreover, harmine reversed the inhibition of lordosis by the serotonin type 2 (5-HT2) antagonists pirenperone and ketanserin in rats primed with estradiol benzoate and progesterone. These results suggest that harmine facilitates lordosis by enhancing activity at 5-HT2 receptors.

Alkaloids↗

Receptivity in Mongolian gerbils: dose and temporal parameters of ovarian hormone administration.

The dose and temporal effects of oestrogen and progesterone treatment on the induction of receptivity in female Mongolian gerbils were investigated. One group of animals was primed with 10 micrograms oestradiol benzoate (OB) 48 and 24 h prior to testing and received 500 micrograms progesterone (Pr) 0, 1, 2, 3, 6, 9, 12, 15, 18, 21 or 24 h prior to testing. These subjects were found to exhibit high levels of receptivity from hour 2 to hour 18. This is similar to the reported duration of heat during natural oestrus. A second group of animals were primed with 10 micrograms OB and were then given either 0, 10, 50, 100, 250 or 500 micrograms Pr 3 h prior to testing. Results indicated that the administration of 100 micrograms Pr could elicit high levels of receptivity. A final group of animals were given either 0.5, 1.0, 5.0 or 10.0 micrograms OB 48 and 24 h before testing and then 100 micrograms Pr 3 h prior to testing. It was found that only the 10 micrograms dose of OB elicited high levels of receptivity in these animals.

Animals↗

Food intake, body weight and lordosis in male and female mongolian gerbils: effects of ovarian steroids.

The effects of gonadectomy and ovarian hormone treatment on food intake, body weight, and lordosis in male and female Mongolian gerbils were examined. In female gerbils, a significant decrease in food intake and body weight was observed after ovariectomy, with estradiol benzoate (1, 10, or 100 micrograms/day) increasing food intake in a dose dependent fashion. However, the dose of estrogen (1 microgram) that restored food intake and body weight to control levels in ovariectomized animals was lower than that required to elicit maximal sexual receptivity. Progesterone, when given in conjunction with estrogen, significantly facilitated the effect of estrogen on food intake without further altering body weight. In male gerbils, castration produced a significant but transient increase in body weight and a delayed increase in food intake. Unlike female gerbils, male gerbils exhibited no significant alterations in food intake, body weight, or lordosis in response to treatment with ovarian steroids. The present results are compared to those obtained in other species.

Animals↗

Serotonin antagonist pirenperone inhibits sexual behavior in the male rat: attenuation by quipazine.

Peripheral administration of the serotonin (5-HT) antagonist pirenperone produced a dose dependent inhibition of sexual behavior in sexually naive and experienced male rats. In Experiment 1, both 75 micrograms/kg and 150 micrograms/kg pirenperone significantly reduced the proportion of naive males mounting, while 150 micrograms/kg also reduced the proportion of naive males intromitting and ejaculating. In Experiment 2, both 75 micrograms/kg and 150 micrograms/kg pirenperone significantly increased mount and intromission latencies in sexually experienced males, as well as decreased intromission frequency, with 150 micrograms/kg more potent in each regard. The 150 micrograms/kg dose also increased the post-ejaculatory interval, and decreased both mount frequency and copulatory efficiency. In Experiment 3, both 150 micrograms/kg pirenperone and 3 mg/kg of the 5-HT agonist quipazine produced significant inhibition of male sexual behavior; however, when co-administered, inhibitory effects of each drug were significantly attenuated. The mutual attenuation of effects by a 5-HT agonist and a 5-HT antagonist suggests that the observed effects of both of these drugs were serotonergically mediated. In the final experiment, the 5-HT antagonist ketanserin was shown to inhibit sexual behavior in a manner similar to that of pirenperone. Results suggest a facilitatory, as well as an inhibitory role for 5-HT in male sexual behavior.

Animals↗

A facilitatory role for serotonin in the sexual behavior of the female rat.

The peripheral administration of the serotonin type 2 receptor (5-HT2) antagonist pirenperone inhibited sexual receptivity in ovariectomized female rats primed either chronically with estradiol benzoate (EB), or acutely with EB plus varying doses of progesterone. An inhibition occurred at 50, 100 and 150 but not 25 micrograms/kg pirenperone. Increasing the dose of progesterone did not attenuate the inhibitory effect of pirenperone. Two other 5-HT2 antagonists, ketanserin (2.5 mg/kg) and spiperone (250 micrograms/kg), also inhibited receptivity in females primed with EB and progesterone. The inhibitory effect of pirenperone on receptivity was attenuated by the 5-HT agonist quipazine (3 mg/kg), though quipazine alone had no effect on receptivity. Whereas the 5-HT antagonist methysergide (3 mg/kg) failed to have an effect on receptivity in EB-primed females, methysergide co-administered with quipazine facilitated receptivity. Pirenperone also inhibited proceptivity in females primed with EB and progesterone. Although quipazine did not attenuate the pirenperone-induced inhibition of proceptivity, quipazine alone increased proceptivity. Moreover, quipazine facilitated proceptivity in EB-primed rats whether progesterone was present or absent. The results suggest that 5-HT may serve both a facilitatory and inhibitory role in female sexual behavior, perhaps reflecting 5-HT2 and 5-HT1 receptor activity, respectively.

Animals↗

Cholecystokinin-octapeptide produces inhibition of lordosis in the female rat.

The peripheral administration of 3 micrograms/kg CCK-8 produced inhibition of lordosis behavior in ovariectomized female rats primed with estradiol benzoate (EB) and progesterone (P). In Experiment 2, an interaction between CCK-8 and P was evident, with the inhibitory effects of CCK-8 being observed with P doses of 100 and 150 micrograms, but not 250 micrograms. No interaction between CCK-8 and EB was evident, as CCK-8 had no effect on lordosis behavior induced by chronic administration of EB alone. The ineffectiveness of CCK-8 in animals treated with high doses of P, or EB administered chronically, suggests that CCK-8 does not inhibit lordosis via a toxic or non-specific mechanism.

Animals↗

Antagonism of estrogen-induced lordosis by corticosterone in adrenalectomized-ovariectomized female rats and mice.

Previous experimentation has established that adrenalectomy can facilitate lordosis in ovariectomized estrogen-primed female rats. Experiment 1 examined the role of adrenal steroids in this effect, the results indicating an attenuation with chronic corticosterone but not with desoxycorticosterone or progesterone administration. Experiment 2 established a dose-response curve for this corticosterone effect. Experiments 3 and 4 indicated that corticosterone administration inhibits lordosis when it precedes estrogen administration. Experiment 5 demonstrated that corticosterone also inhibits estrogen-induced lordosis in mice. These data suggest that corticosterone may modulate estrogen-mediated behavior in rodents.

Adrenalectomy↗

Effects of dexamethasone, corticosterone, and ACTH on lordosis in ovariectomized and adrenalectomized-ovariectomized rats.

The involvement of the pituitary-adrenocortical axis in the control of the lordosis reflex was investigated; In Experiment 1, estrogen-primed ovariectomized (ovx) and adrenalectomized-ovariectomized (adx-ovx) females were treated chronically with dexamethasone, a compound blocking ACTH release from the pituitary. Dexamethasone inhibited lordosis, effectively blocking an adrenalectomy-induced facilitation of the reflex. In Experiment 2, corticosterone was similarly administered chronically; this compound also inhibited lordosis in adx-ovx females. In Experiment 3, acute peripheral administration of synthetic ACTH caused a marked increase in lordosis in ovx females. The results suggest that in the adrenally intact animal, ACTH may exert its effect through adrenal steroids. An acute elevation of adrenal steroids may increase lordosis, whereas a chronic elevation may decrease it.

Adrenalectomy↗

An easily constructed durable chronic intracerebral cannula system.

A simple, inexpensive, and rugged intracerebral cannula system is described and construction details are provided for both guide and injection cannula assemblies. The guide cannula assembly is easily and quickly molded from dental acrylic cement and has a protective acrylic collar surrounding the end of the actual guide cannula. This system is believed to offer some advantage over current methodologies in terms of expense, durability and ease of construction and is well suited to use in rodents.

Animals↗